Association of glutathione s-transferase T1 and M1 genotypes with chronic liver diseases among filipinos

International Journal of Molecular Epidemiology and Genetics

Volumn 3, Issue 2, 2012, Pages 153-159

  Baclig, Michael O ^a   Alvarez, May R ^a   Lozada, Xerxes Morgan R ^a   Mapua, Cynthia A ^a   Lozano Kühne, Jingky P ^a   Dimamay, Mark Pierre S ^a   Natividad, Filipinas F ^a   Gopez Cervantes, Juliet ^a   Matias, Ronald R ^a  

^a ST LUKE S MEDICAL CENTER   (Philippines)

Author keywords

Chronic liver disease; Filipino; GSTM1; GSTT1; Hepatitis b virus; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FILIPINO; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

HEPATITIS B VIRUS;

EID: 84861790062     PISSN: None     EISSN: 19481756     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Abdel-Rahman SZ, El-Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Letters 1996; 107: 229-233.
2. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-283.
3. Rebbeck TR. Molecular epidemiology of the human glutathione S transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-743.
4. Katoh T, Inatomi H, Nagaoka A, Sugita A. Cyto-chrome P4501A1 gene polymorphism and ho-mozygous deletion of the glutathione S trans-ferase M1 gene in urothelial cancer patients. Carcinogenesis 1995; 16: 655-657.
5. Chen CL, Liu Q, Pui CH, Rivera GK, Sandlund JT, Ribeiro R, Evans WE, Relling MV. Higher frequency of glutathione S transferase deletions in black children with acute lymphoblastic leukemia. Blood 1997; 89: 1701-1707.
6. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159-1164.
7. Welfare M, Adeokun AM, Bassendine MF, Daly AK. Polymorphisms in GSTP1 GSTM1 and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 289-292.
8. Dialyna IA, Miyakis S, Georgatou N, Spandidos DA. Genetic polymorphisms of CYP1A1 GSTM1 and GSTT1 genes and lung cancer risk. Oncology Reports 2003; 10: 1829-1835.
9. Deng ZL, Wei YP, Ma Y. Polymorphism of glutathione S transferase mu1 and theta 1 genes and hepatocellular carcinoma in Southern Guangxi China. World J Gastroenterol 2005; 11: 272-274.
10. Gelatti U, Covolo L, Talamini R, Tagger A, Bar-bone F, Martelli C, Cremaschini F, Franceschi S, Ribero ML, Garte S, Nardi G, Donadon V, Do-nato F. N-acetyltansferase-2 glutathione S transferase M1 and T1 genetic polymorphisms cigarette smoking and hepatocellular carcinoma: a case-control study. Int J Cancer 2005; 115: 301-306.
11. Ladero JM, Martínez C, García-Martín E, Ropero P, Briceño O, Villegas A, Díaz-Rubio M, Agúndez JA. Glutathione S transferase M1 and T1 genetic polymorphisms are not releated to the risk of hepatocellular carcinoma: a study in the Spanish population. Eur J Cancer 2006; 42: 73-77.
12. Mohammadzadeh GS, Yaghmaei B, Allameh A, Hassani P, Noorinayer B, Zali MR. Polymorphisms of glutathione S transferase M1 T1 and P1 in patients with HBV related liver cirrhosis chronic hepatitis and normal carriers. Clin Biochem 2006; 39: 46-49.
13. Kandemir O, Tamer L, Tasdelen B. Effects of GSTT1 GSTM1 and GSTP1 gene polymorphism on the course of hepatitis B virus infection. Hepatogastroenterology 2008; 55: 1729-1733.
14. Yu L, Wang CY, Xi B, Sun L, Wang RQ, Yan YK, Zhu LY. GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World J Gastroenterol 2011; 17: 3248-3256.
15. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D, Zhou W. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol 2010; 53: 508-518.
16. Zeng GB, Wen SJ, Wang ZH, Yan L, Sun J, Hou JL. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J Gastroenterol 2004; 10: 3132-3136.
17. Rimando MG, Chua MN, Yuson E, de Castro-Bernas G, Okamoto T. Prevalence of GSTT1 GSTM1 and NQ01 (609C>T) in Filipino children with acute lymphoblastic leukemia. Biosci Rep 2008; 28: 117-124.
18. Esser C, Tomiukw J. Reporting Hardy Weinberg tests in case control studies: reasons for caution but not for panic reactions. J Invest Derma-tol 2005; 124: 1082-1083.
19. Munaka M, Munaka M, Kohshi K, Kawamoto T, Takasawa S, Nagata N, Itoh H, Oda S, Kato T. Genetic polymorphisms of tobacco and alcohol related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol 2003; 129: 355-360.
20. Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW, Wang Q, Wu DR, Santella RM. Genetic polymorphisms of glutathione S transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis 2001; 22: 1289-1294.
21. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ. Polymorphisms in XRCC1 and glutathione S transferase genes and hepatitis B related hepatocellular carcinoma. J National Cancer Institute 2003; 95: 1485-1488.
22. White DL, Li D, Nurgalieva Z, El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 2008; 167: 377-389.
23. Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N. GSTM1 null and NAT2 slow acetylation genotypes smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 2011; 32: 182-189.
24. Sobel HL, Mantaring JB, Cuevas F, Ducusin JV, Thorley M, Hennessey KA, Nyunt-US. Implementing a national policy for hepatitis B birth dose vaccination in Philippines: lessons for improved delivery. Vaccine 2011; 29: 941-945.
25. Grandjacques C, Pradat P, Stuyver L, Chevallier M, Chevallier P, Pichoud C, Maisonnas M, Trépo C, Zoulim F. Rapid detection of genotypes and mutations in the pre core promoter and the pre core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 2000; 3: 430-439.
26. Zhao Y, Zhang XY, Guo JJ, Zeng AZ, Hu JL, Huang WX, Shan YL, Huang AL. Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real time PCR assay. J Clin Microbiol 2010; 48: 3690-3697.
27. Malmstrom S, Berglin-Enquist I, Lindh M. Novel method for genotyping hepatitis B virus on the basis of TaqMan real time PCR. J Clin Microbiol 2010; 48: 1105-1111.
28. Ali MM, Hasan F, Ahmad S, Al-Nakib W. Comparative evaluation of INNO-LiPA HBV assay direct DNA sequencing and subtractive PCR RFLP for genotyping of clinical HBV isolates. Virol J 2010; 7: 111.
29. Ma Y, Ding Y, Juan F, Dou XG. Genotyping the hepatitis B virus with a fragment of the HBV DNA polymerase gene in Shenyang China. Virol J 2011; 8: 315.
30. Malmström S, Berglin-Enquist I, Lindh M. Novel method for genotyping hepatitis B virus on the basis of TaqMan real time PCR. J Clin Microbiol 2010; 48: 1105-1111.
31. Batoctoy KS, Tseng TC, Kao JH, Quiza FE, Garcia LH, Lao-Tan J. HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City Philippines. Hepatol Int 2011; 5: 774-781.
32. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterol-ogy 2000; 118: 554-559.
33. Valsamakis A. Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev 2007; 20: 426-439.